Targeting the SARS-CoV-2-spike protein: from antibodies to miniproteins and peptides

Fighting COVID-19 with high affinity reagents: this review article summarizes the discovery of several classes of (bio) molecules targeting the SARS-CoV-2 spike protein.

Bibliographic Details
Main Author: Pomplun, Sebastian Johannes
Other Authors: Massachusetts Institute of Technology. Department of Chemistry
Format: Article
Published: Royal Society of Chemistry (RSC) 2021
Online Access:https://hdl.handle.net/1721.1/130898
_version_ 1826212613292294144
author Pomplun, Sebastian Johannes
author2 Massachusetts Institute of Technology. Department of Chemistry
author_facet Massachusetts Institute of Technology. Department of Chemistry
Pomplun, Sebastian Johannes
author_sort Pomplun, Sebastian Johannes
collection MIT
description Fighting COVID-19 with high affinity reagents: this review article summarizes the discovery of several classes of (bio) molecules targeting the SARS-CoV-2 spike protein.
first_indexed 2024-09-23T15:29:53Z
format Article
id mit-1721.1/130898
institution Massachusetts Institute of Technology
last_indexed 2024-09-23T15:29:53Z
publishDate 2021
publisher Royal Society of Chemistry (RSC)
record_format dspace
spelling mit-1721.1/1308982022-09-29T14:48:57Z Targeting the SARS-CoV-2-spike protein: from antibodies to miniproteins and peptides Pomplun, Sebastian Johannes Massachusetts Institute of Technology. Department of Chemistry Fighting COVID-19 with high affinity reagents: this review article summarizes the discovery of several classes of (bio) molecules targeting the SARS-CoV-2 spike protein. 2021-06-02T20:07:16Z 2021-06-02T20:07:16Z 2021-02 2020-11 Article http://purl.org/eprint/type/JournalArticle 2632-8682 https://hdl.handle.net/1721.1/130898 Pomplun, Sebastian. "Targeting the SARS-CoV-2-spike protein: from antibodies to miniproteins and peptides." RSC Medicinal Chemistry 12, 2 (February 2021): 197. © 2021 The Royal Society of Chemistry https://doi.org/10.1039/D0MD00385A RSC Medicinal Chemistry Creative Commons Attribution NonCommercial License 4.0 https://creativecommons.org/licenses/by-nc/4.0/ application/pdf Royal Society of Chemistry (RSC) Royal Society of Chemistry (RSC)
spellingShingle Pomplun, Sebastian Johannes
Targeting the SARS-CoV-2-spike protein: from antibodies to miniproteins and peptides
title Targeting the SARS-CoV-2-spike protein: from antibodies to miniproteins and peptides
title_full Targeting the SARS-CoV-2-spike protein: from antibodies to miniproteins and peptides
title_fullStr Targeting the SARS-CoV-2-spike protein: from antibodies to miniproteins and peptides
title_full_unstemmed Targeting the SARS-CoV-2-spike protein: from antibodies to miniproteins and peptides
title_short Targeting the SARS-CoV-2-spike protein: from antibodies to miniproteins and peptides
title_sort targeting the sars cov 2 spike protein from antibodies to miniproteins and peptides
url https://hdl.handle.net/1721.1/130898
work_keys_str_mv AT pomplunsebastianjohannes targetingthesarscov2spikeproteinfromantibodiestominiproteinsandpeptides